drugset / Trial / NCT07269704

Effect of Nutritional Supplement Alpha-ketoglutarate for Age-related Ocular Disease

NCT07269704 ↗

Phase 0 Completed 17 enrolled Stanford University
NaSingle-groupOpen-labelPrevention

Summary

The aims of the study are as follows: 1. Determine how the eye absorbs supplements taken orally. 2. Look for specific signs in the proteins and substances in the eyes of people with eye diseases who are also taking nutritional supplements.

Timeline

Start
2023-08-15
Primary completion
2025-06-10
Completion
2025-06-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcium alpha-ketoglutarate Unknown 2 g Oral

Indications